作者:Elena Valverde、Francesc X. Sureda、Santiago Vázquez
DOI:10.1016/j.bmc.2014.03.025
日期:2014.5
A new series of benzopolycyclic amines active as NMDA receptor antagonists were synthesized. Most of them exhibited increased activity compared with related analogues previously published. All the tested compounds were more potent than clinically approved amantadine and one of them displayed a lower IC50 value than memantine, an anti-Alzheimer's approved drug. (C) 2014 Elsevier Ltd. All rights reserved.